Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • PZWL
  • Reduced price
Stroke Prevention in Atrial Fibrillation

Stroke Prevention in Atrial Fibrillation

9780323554299
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 30 DAYS
510.24 zł
433.71 zł Save 76.53 zł Tax included
Lowest price within 30 days before promotion: 433.71 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description

Get a quick, expert overview of stroke risks among patients with treated and untreated atrial fibrillation, in addition to best practices for management and treatment of patients with atrial fibrillation to minimize stroke risks. This concise, clinically-focused resource by Dr. Greg Flaker consolidates todays available information on this timely topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee cardiologists as well as general practitioners treating and monitoring these patients.

Product Details
Elsevier
60115
9780323554299
9780323554299

Data sheet

Publication date
2018
Issue number
1
Cover
paperback
Pages count
202
Dimensions (mm)
197 x 240
Weight (g)
430

  • 1. Economic and Social Overview of Stroke Related to Atrial Fibrillation

    2. Pharmacology of Anticoagulants- VKA and NOACs

    3. Anticoagulation Drug Trials for Stroke Prevention in Atrial Fibrillation

    4. Risk Stratification

    5. Subclinical Atrial Fibrillation

    6. The New Anticoagulation Clinic

    7. Management of Bleeding Associated with Anticoagulation

    8. Periprocedural Management

    9. Special Situations: Anticoagulation for Cardioversion

    10. Special Situations: Anticoagulation for Ablation

    11. Surgical and Implanted Devices for the Left Atrial Appendage

    12. Anticoagulation of the Atrial Fibrillation Patient with Other Medical Conditions

    13. Stroke and Atrial Fibrillation: The Neurologists Perspective

    14. Atrial Fibrillation and Chronic Kidney Disease

Comments (0)

  • Frequently purchased together

    No products available